1 month ago
21
Argus
•
Apr 25, 2025
Bristol-Myers Squibb Company: HOLD arsenic Legacy Portfolio declines resistance connected results
Summary
Bristol-Myers Squibb is simply a starring worldwide biopharmaceutical company. Its products absorption connected oncology, immunology, and cardiovascular conditions. The institution completed its merger with Celgene
Upgrade to statesman utilizing premium probe reports and get truthful overmuch more.
Exclusive reports, elaborate institution profiles, and best-in-class commercialized insights to instrumentality your portfolio to the adjacent level
Upgrade
Analyst Profile
Jasper Hellweg
Associate Analyst: Growth Pharmaceutical, Medical Technology & Financial Technology
At Argus Research, Jasper covers the Growth Pharmaceutical, Medical Technology, and Financial Technology companies. He received his undergraduate grade from Boston University, graduating cum laude with a Bachelor of Science grade successful Business Administration with concentrations successful Entrepreneurship and Marketing. Prior to joining Argus, Jasper worked successful a assortment of industries, ranging from concern tradeshow absorption to philharmonic instrumentality manufacturing. He started his vocation astatine Argus successful the Research section and has since widened his scope to besides see becoming a regular contributor for the Market Movers and Market Digest publications, the Vickers Weekly Insider Report and Argus' bespoke probe connected IPOs.
English (CA) · 
English (US) · 
Spanish (MX) ·